In middle-aged and older adults, both the total volume of sedentary time and its accrual in prolonged, uninterrupted sessions are associated with all-cause mortality, a recent study found. The study included 7,985 black and white adults aged ≥45 years and examined the association between objectively measured sedentary behavior and all-cause mortality. Hazard ratios (HRs) were calculated comparing quartiles 2 through 4 to quartile 1 for each exposure in models that included moderate-to-vigorous physical activity. Researchers found:
- Over a median follow-up of 4 years, 340 participants died.
- Greater sedentary time (HR 1.22, 1.61, and 2.63) and longer sedentary bout duration (HR 1.03, 1.22, and 1.96) were both associated with a greater risk for all-cause mortality.
- Participants classified as high for both sedentary characteristics (high sedentary time and high bout duration) had the greatest risk for death.
Diaz KM, Howard VJ, Hutto B, et al. Patterns of sedentary behavior and mortality in U.S. middle-aged and older adults: A national cohort study. [Published online ahead of print September 12, 2017]. Ann Intern Med. doi:10.7326/M17-0212.
This study lends further support to the growing body of evidence deomonstrating that prolonged periods of inactivity, i.e., sedentary behavior, is hazardous to your health. Sedentary behavior is distinct from a lack of moderate-to-vigorous physical activity (MVPA), and it is concerning that even those individuals who spend more time engaged in MVPA often have similar sedentary time as those who are less physically active. Sedentary behavior is a risk factor for cardiovascular disease, diabetes mellitus, and all-cause mortality.1 When we counsel patients, we should counsel about diet and exercise, as well as decreasing sedentary behavior. —Neil Skolnik, MD
- Young DR, Hivert MF, Alhassan S, et al. Sedentary behavior and cardiovascular morbidity and mortality: A science advisory from the American Heart Association. Circulation. 2016;134(13):262-79. doi:10.1161/CIR.0000000000000440.
This Week's Must Reads
LAMA + LABA for Patients with Stable COPD, JAMA; 2017 Oct 3; Horita, Nagashima, et al
Assessing CCTA for Patients with Suspected CAD, JAMA Intern Med; ePub 2017 Oct 2; Foy, et al
Rivaroxaban + Aspirin for CV Prevention, N Engl J Med; 2017 Oct 5; Eikelboom, et al
Exenatide Effects in Patients with Parkinson Disease, Lancet; 2017 Oct 7; Athauda, Maclagan, et al
FDA Approves Fast-Acting Mealtime Insulin, Novo Nordisk news release; 2017 Sep 29
Must Reads in Preventive Care
Sedentary Behavior and Mortality in Older Adults, Ann Intern Med; ePub 2017 Sep 12; Diaz, et al
Do Patient Beliefs Impact Medication Adherence?, J Am Board Fam Med; 2017 May-Jun; Gagnon, et al
Assessing 30-Minute Office BP Monitoring, Ann Fam Med; 2017 Mar/Apr; Bos, Buis
Cancer Screening Test Use in US Adults, MMWR; ePub 2017 Mar 3; White, et al
Do Reminder Devices Aid in Medication Adherence?, JAMA Intern Med; ePub 2017 Feb 27; Choudhry, et al